BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:Central Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:Central Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260331T130000
DTEND;TZID=America/Chicago:20260331T143000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Revisions to QM Calculations For Use of Antipsychotics - WEBINAR - #WRQM2601
DESCRIPTION:This presentation provides an overview of the updated CMS quality measure for the percentage of long-stay residents in nursing homes who receive antipsychotic medications. Effective with the Minimum Data Set (MDS) 3.0 Quality Measures User's Manual Version 18.0 (starting January 1\, 2026\, for calculations and public reporting)\, the measure has been re-specified to incorporate additional data sources for greater accuracy and comprehensiveness. The session will explore the rationale for these changes\, the revised calculation methodology\, impacts on quality reporting and star ratings\, and practical strategies for nursing home providers to adapt and improve performance.This program is NAB approved for 1.5 Continuing Education Hours \nObjectives: Participants will be able to: Describe the key updates to the long-stay antipsychotic medication quality measure in MDS 3.0 QM User's Manual v18.0. Explain the new calculation methodology\, including data sources and risk adjustments. Identify the potential impacts on nursing home quality ratings and public reporting. Outline evidence-based strategies to reduce unnecessary antipsychotic use and optimize measure performance.Speaker: Linda Farrar\, RN\, LNHA\, Oklahoma Clinical Consultant\, LICA MedMan
X-ALT-DESC;FMTTYPE=text/html:This presentation provides an overview of the updated CMS quality measure for the percentage of long-stay residents in nursing homes who receive antipsychotic medications. \;
Effective with the Minimum Data Set (MDS) 3.0 Quality Measures User'\;s Manual Version 18.0 (starting January 1\, 2026\, for calculations and public reporting)\, the measure has been re-specified to incorporate additional data sources for greater accuracy and comprehensiveness. \;
The session will explore the rationale for these changes\, the revised calculation methodology\, impacts on quality reporting and star ratings\, and practical strategies for nursing home providers to adapt and improve performance.
This program is NAB approved for 1.5 Continuing Education Hours \;
Objectives: \;
Participants will be able to: \;
·\; Describe the key updates to the long-stay antipsychotic medication quality measure in MDS 3.0 QM User'\;s Manual v18.0. \;
·\; Explain the new calculation methodology\, including data sources and risk adjustments. \;
·\; Identify the potential impacts on nursing home quality ratings and public reporting. \;
·\; Outline evidence-based strategies to reduce unnecessary antipsychotic use and optimize measure performance.
Speaker: \;Linda Farrar\, RN\, LNHA\, Oklahoma Clinical Consultant\, LICA MedMan
LOCATION:
UID:e.1471.1384478
SEQUENCE:3
DTSTAMP:20260824T233204Z
URL:https://members.careoklahoma.com/education-classes/Details/revisions-to-qm-calculations-for-use-of-antipsychotics-webinar-wrqm2601-1634643?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR